CK Pharma Support SRL
The score of CK Pharma Support shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -83 % Total assets -13 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
CK Pharma Support's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 66,578 € | ||||
| Equity | 20,460 € | ||||
| Cash | 122,723 € | ||||
| EBITDA | 116,593 € | ||||
| Total assets | 263,572 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 16 Mar 2026
- Year ended 31 Dec 2024filed on 10 Jun 2025
- Year ended 31 Dec 2023filed on 24 Jun 2024
- Year ended 31 Dec 2022filed on 12 Jun 2023
- Year ended 31 Dec 2021filed on 10 Jun 2022
CK Pharma Support's financial analysis
- Solvency7.8%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of CK Pharma Support
CK Pharma Support's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0707.549.771
- VAT number
- BE0707549771
- Peppol
- Registered · 0208:0707549771 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 01 Oct 2018
- Registered office
- 2260 Westerlo
- Latest accounts
- 2025 · filed on 16 Mar 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
CK Pharma Support (SRL) has been based in Westerlo since 2018, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 66,578 € and equity of 20,460 €; its revenue is not published. Its solvency stands at 7.8%, below the median of its sector (44.2%).
Companies similar to CK Pharma Support
Companies in the same business, of comparable size and area, outside its group.
- Vivapharma Retail sale of pharmaceutical products Auderghem · balance sheet 236,296 €
- Pharmacie Agueznay Retail sale of pharmaceutical products Jette · balance sheet 228,907 €
- Apotheek Ruppol Retail sale of pharmaceutical products Sint-Truiden · balance sheet 266,201 €
- Melbuj Retail sale of pharmaceutical products Wemmel · balance sheet 237,909 €
- Biomedim Retail sale of pharmaceutical products Plombières · balance sheet 430,148 €
- Ptms Consultancy Retail sale of pharmaceutical products Londerzeel · balance sheet 192,606 €
- AZ.Pharmabel Retail sale of pharmaceutical products Schaerbeek · balance sheet 479,564 €
- I & CM Marbotin Retail sale of pharmaceutical products Schaerbeek · balance sheet 323,588 €
Frequently asked questions about CK Pharma Support
What is the revenue of CK Pharma Support?
CK Pharma Support files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of CK Pharma Support?
In Belgium, the VAT number is the company number prefixed with BE: BE0707549771 for CK Pharma Support, if the company is VAT-registered. Its company number (CBE) is 0707.549.771.
Where is the registered office of CK Pharma Support?
According to the CBE register, the registered office of CK Pharma Support is in 2260 Westerlo.
What is the equity of CK Pharma Support?
At the close of the 2025 financial year, the equity of CK Pharma Support amounts to 20,460 €, a solvency of 7.8% of total assets.
Who manages CK Pharma Support?
The register lists 1 active mandates at CK Pharma Support. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of CK Pharma Support
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →